5 HTP 100 mg
Natural health product licensed in Canada
- Other names
- 5 HTP 5-hydroxytryptophan 100 mg, Horbäach 5 Htp 100 Mg, Horbäach 5 Htp 5-Hydroxytryptophan 100 Mg
- Licence holder
- Piping Rock Health Products
- NPN or DIN-HM
- 80061670
- Status
- Active licence
- Licence date
- 8 June 2015
- Revision date
- 10 February 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-5-hydroxytryptophane Source : 5-HTP | 100 milligramme | Not calculated |
| L-5-hydroxytryptophane Source : Griffonia simplicifolia, graine | 100 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Farine de riz blanc, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Helps to promote healthy mood balance. Used as a sleep aid. Helps to relieve symptoms of fibromyalgia. Helps to reduce the severity and duration of migraine headaches when taken as a prophylactic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. Some people may experience diarrhea, nausea, vomiting and abdominal pain.
- Contre-indications
Do not use if you have scleroderma.
- Précautions et mises en garde
For use as a sleep aid, consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking carbidopa or drugs/supplements with serotonergic activity. These may include, but are not limited to, L-tryptophan, S-adenosylmethionine (SAMe), St. John's wort, antidepressants, pain killers, over the counter cough and cold medication containing dextromethorphan, anti-nausea medication and anti-migraine medication. Discontinue use and consult a health care practitioner if you show signs of weakness, oral ulcers, or abdominal pain accompanied by severe muscle pain. Discontinue use and consult a health care practitioner if you experience skin changes.
Source
Official Health Canada record, licence 80061670
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging